| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.00059 | 1 |